Furthermore, the dual blockade of PD-1 and LAG3 restored T-cell function across ccRCC, sarcomatoid-differentiated ccRCC, and chRCC tumor samples [164]. This evidence concerns the gene LAG3 and chromophobe renal cell carcinoma.